Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy: a Prospective, Multi-site, Randomised, Sham-controlled, Single-blind (Outcome Assessor-blinded) Study.

NCT03840395 is registered in ClinicalTrials.gov with Phagenesis Ltd. as lead sponsor.

NCT NCT03840395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03840395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy: a Prospective, Multi-site, Randomised, Sham-controlled, Single-blind (Outcome Assessor-blinded) Study.
Lead sponsor
Phagenesis Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
June 17, 2019
Completion date
December 31, 2025
Enrollment
72 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

dysphagia